APA (7th ed.) Citation

AR, S., AGM, C., MS, D. O., SJ, B., LAA, G., PI, S., . . . D, H. (2025). Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study. Acta dermato-venereologica, 105, adv44165. https://doi.org/10.2340/actadv.v105.44165

Chicago Style (17th ed.) Citation

AR, Schlösser, Caron AGM, Den Ouden MS, Baart SJ, Gerbens LAA, Spuls PI, Nijsten TEC, Schappin R, and Hijnen D. "Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study." Acta Dermato-venereologica 105 (2025): adv44165. https://doi.org/10.2340/actadv.v105.44165.

MLA (9th ed.) Citation

AR, Schlösser, et al. "Successful Dose Reduction of Janus-kinase Inhibitors in Well-controlled Atopic Dermatitis: A Prospective, Multicentre, Real-world Study." Acta Dermato-venereologica, vol. 105, 2025, p. adv44165, https://doi.org/10.2340/actadv.v105.44165.